Cargando…
Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma
PURPOSE: To study acquired color vision and visual field defects in patients with ocular hypertension (OH) and early glaucoma. METHODS: In a prospective study we evaluated 99 eyes of 56 patients with OH without visual field defects and no hereditary color deficiencies, followed up for 4 to 6 years (...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709000/ https://www.ncbi.nlm.nih.gov/pubmed/19668575 |
_version_ | 1782169257691316224 |
---|---|
author | Papaconstantinou, Dimitris Georgalas, Ilias Kalantzis, George Karmiris, Efthimios Koutsandrea, Chrysanthi Diagourtas, Andreas Ladas, Ioannis Georgopoulos, Gerasimos |
author_facet | Papaconstantinou, Dimitris Georgalas, Ilias Kalantzis, George Karmiris, Efthimios Koutsandrea, Chrysanthi Diagourtas, Andreas Ladas, Ioannis Georgopoulos, Gerasimos |
author_sort | Papaconstantinou, Dimitris |
collection | PubMed |
description | PURPOSE: To study acquired color vision and visual field defects in patients with ocular hypertension (OH) and early glaucoma. METHODS: In a prospective study we evaluated 99 eyes of 56 patients with OH without visual field defects and no hereditary color deficiencies, followed up for 4 to 6 years (mean = 4.7 ± 0.6 years). Color vision defects were studied using a special computer program for Farnsworth–Munsell 100 hue test and visual field tests were performed with Humphrey analyzer using program 30–2. Both tests were repeated every six months. RESULTS: In fifty-six eyes, glaucomatous defects were observed during the follow-up period. There was a statistically significant difference in total error score (TES) between eyes that eventually developed glaucoma (157.89 ± 31.79) and OH eyes (75.51 ± 31.57) at the first examination (t value 12.816, p < 0.001). At the same time visual field indices were within normal limits in both groups. In the glaucomatous eyes the earliest statistical significant change in TES was identified at the first year of follow-up and was −20.62 ± 2.75 (t value 9.08, p < 0.001) while in OH eyes was −2.11 ± 4.36 (t value 1.1, p = 0.276). Pearson’s coefficient was high in all examinations and showed a direct correlation between TES and mean deviation and corrected pattern standard deviation in both groups. CONCLUSION: Quantitative analysis of color vision defects provides the possibility of follow-up and can prove a useful means for detecting early glaucomatous changes in patients with normal visual fields. |
format | Text |
id | pubmed-2709000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27090002009-08-10 Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma Papaconstantinou, Dimitris Georgalas, Ilias Kalantzis, George Karmiris, Efthimios Koutsandrea, Chrysanthi Diagourtas, Andreas Ladas, Ioannis Georgopoulos, Gerasimos Clin Ophthalmol Original Research PURPOSE: To study acquired color vision and visual field defects in patients with ocular hypertension (OH) and early glaucoma. METHODS: In a prospective study we evaluated 99 eyes of 56 patients with OH without visual field defects and no hereditary color deficiencies, followed up for 4 to 6 years (mean = 4.7 ± 0.6 years). Color vision defects were studied using a special computer program for Farnsworth–Munsell 100 hue test and visual field tests were performed with Humphrey analyzer using program 30–2. Both tests were repeated every six months. RESULTS: In fifty-six eyes, glaucomatous defects were observed during the follow-up period. There was a statistically significant difference in total error score (TES) between eyes that eventually developed glaucoma (157.89 ± 31.79) and OH eyes (75.51 ± 31.57) at the first examination (t value 12.816, p < 0.001). At the same time visual field indices were within normal limits in both groups. In the glaucomatous eyes the earliest statistical significant change in TES was identified at the first year of follow-up and was −20.62 ± 2.75 (t value 9.08, p < 0.001) while in OH eyes was −2.11 ± 4.36 (t value 1.1, p = 0.276). Pearson’s coefficient was high in all examinations and showed a direct correlation between TES and mean deviation and corrected pattern standard deviation in both groups. CONCLUSION: Quantitative analysis of color vision defects provides the possibility of follow-up and can prove a useful means for detecting early glaucomatous changes in patients with normal visual fields. Dove Medical Press 2009 2009-06-02 /pmc/articles/PMC2709000/ /pubmed/19668575 Text en © 2009 Papaconstantinou et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Papaconstantinou, Dimitris Georgalas, Ilias Kalantzis, George Karmiris, Efthimios Koutsandrea, Chrysanthi Diagourtas, Andreas Ladas, Ioannis Georgopoulos, Gerasimos Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma |
title | Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma |
title_full | Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma |
title_fullStr | Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma |
title_full_unstemmed | Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma |
title_short | Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma |
title_sort | acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709000/ https://www.ncbi.nlm.nih.gov/pubmed/19668575 |
work_keys_str_mv | AT papaconstantinoudimitris acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma AT georgalasilias acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma AT kalantzisgeorge acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma AT karmirisefthimios acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma AT koutsandreachrysanthi acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma AT diagourtasandreas acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma AT ladasioannis acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma AT georgopoulosgerasimos acquiredcolorvisionandvisualfielddefectsinpatientswithocularhypertensionandearlyglaucoma |